45784PAD3
Insulet Corporation
Could not find a ticker for this position, may be a filing error
A maker of the Omnipod, a tubeless, wearable insulin pump worn on the skin that lets people with diabetes manage their insulin without daily injections or tubing. The company was founded in 2000 after co-founder John Brooks' young son was diagnosed with type 1 diabetes, and its name blends "insulin" and "let." Legend has it Brooks first sketched the device's design on a napkin aboard an airplane.
CONVERTIBLEUnderlying: PODDCUSIP: 45784PAD3HealthcareUS1 derivative reporter
2.00% Convertible Senior Notes due 2019
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
